LJM1R — Latvijas Juras Medicinas Centrs AS Income Statement
0.000.00%
Last trade - 00:00- €4.68m
- €3.82m
- €10.19m
- 66
- 50
- 12
- 34
Annual income statement for Latvijas Juras Medicinas Centrs AS, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Interim Report | ARS | ARS | ARS | ARS |
| Standards: | — | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 7.08 | 9.36 | 9.7 | 9.84 | 10.2 |
| Cost of Revenue | |||||
| Gross Profit | 0.593 | 1.22 | 0.775 | 0.376 | 0.31 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 6.81 | 8.48 | 9.07 | 9.85 | 10 |
| Operating Profit | 0.275 | 0.881 | 0.626 | -0.014 | 0.178 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | 0.275 | 0.881 | 0.626 | -0.014 | 0.178 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 0.274 | 0.88 | 0.626 | -0.014 | 0.178 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 0.274 | 0.88 | 0.626 | -0.014 | 0.178 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 0.274 | 0.88 | 0.626 | -0.014 | 0.178 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.33 | 1.09 | 0.784 | -0.012 | 0.162 |
| Dividends per Share |